Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,636.00
Bid: 2,628.00
Ask: 2,630.00
Change: 34.00 (1.31%)
Spread: 2.00 (0.076%)
Open: 2,622.00
High: 2,656.00
Low: 2,614.00
Prev. Close: 2,602.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Composition of the Committees of the BoD of CCHBC

11 Jun 2018 15:20

RNS Number : 0152R
Coca-Cola HBC AG
11 June 2018
 

 

FOR IMMEDIATE RELEASE

 

Coca-Cola HBC AG

Composition of the Committees of the Board of Directors of Coca‑Cola HBC AG

 

 

Zug, Switzerland - 11 June 2018 - Coca‑Cola HBC AG ("Coca‑Cola HBC" or the "Company") announces today that its board of directors (the "Board") has re-appointed all members of the Board Committees.

These re-appointments have been made pursuant to the announcement released by Coca‑Cola HBC on 8 May 2018.

The composition of the Board Committees will be as follows:

Audit Committee

William (Bill) W. Douglas III (Chair)

John P. Sechi

Olusola (Sola) David-Borha

Nomination Committee

Reto Francioni (Chair)

Charlotte J. Boyle

Alexandra Papalexopoulou

Remuneration Committee

Alexandra Papalexopoulou (Chair)

Charlotte J. Boyle

Reto Francioni

Social Responsibility Committee

Anastasios I. Leventis (Chair)

Alexandra Papalexopoulou

José Octavio Reyes

 

This announcement is made pursuant to Listing Rule 9.6.11.

 

 

Enquiries

Coca‑Cola HBC Group

Basak Kotler

Investor Relations Director

Tel: +44 20 37 444 231

 basak.kotler@cchellenic.com

Joanna Kennedy

Investor Relations Manager

Tel: +44 20 37 444 230

 joanna.kennedy@cchellenic.com

Vasso Aliferi

Investor Relations Manager

Tel: +41 44 835 9274

 vasso.aliferi@cchellenic.com

 

International media contact:

Teneo Blue Rubicon

Rob Morgan

Anushka Mathew

Tel: +44 20 7260 2700 robert.morgan@teneobluerubicon.com anushka.mathew@teneobluerubicon.com

 

Greek media contact:

V+O Communications

Argyro Oikonomou

Tel: +30 211 7501219

 ao@vando.gr

 

 

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with a sales volume of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 600 million people. Coca-Cola HBC offers a diverse range of non-alcoholic ready to drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC is ranked beverage industry leader in the Dow Jones Sustainability World and Europe Indices, and is also included in the FTSE4Good Index.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://www.coca-colahellenic.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAZFLFFVQFFBBQ
Date   Source Headline
22nd Feb 20245:30 pmRNSTransaction in Own Shares
22nd Feb 20247:15 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSCoca-Cola HBC acquires BDS Vending in Ireland
20th Feb 20246:15 pmRNSTransaction in Own Shares
20th Feb 20244:01 pmRNSPricing of Issue of Notes
20th Feb 202410:47 amRNSDirector/PDMR Shareholding
20th Feb 20248:41 amRNSLaunch of Issue of Notes
19th Feb 20246:03 pmRNSTransaction in Own Shares
19th Feb 20244:50 pmRNSDirector/PDMR Shareholding
15th Feb 20242:59 pmRNSPublication of Suppl.Prospcts
14th Feb 20247:00 amRNSStrong execution powers a year of growth
7th Feb 20244:45 pmRNSAppointment of Group CFO
1st Feb 202411:35 amRNSIssue of equity and total voting rights
29th Jan 20241:58 pmRNSAppointment of Corporate Broker
18th Jan 20242:54 pmRNSDirector/PDMR Shareholding
18th Jan 20241:29 pmRNSNotice of Results
15th Jan 20244:45 pmRNSCFO stepping down to pursue new role in N. America
4th Jan 20241:45 pmRNSAthens Exchange trading date of ordinary shares
3rd Jan 202412:10 pmRNSDirector/PDMR Shareholding
2nd Jan 202412:02 pmRNSIssue of equity and total voting rights
27th Dec 20237:15 amRNSTransaction in Own Shares
27th Dec 20237:04 amRNSHolding(s) in Company
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Dec 20235:35 pmRNSTransaction in Own Shares
21st Dec 20232:49 pmRNSDirector/PDMR Shareholding
20th Dec 20235:20 pmRNSTransaction in Own Shares
20th Dec 20237:15 amRNSTransaction in Own Shares
19th Dec 202312:50 pmRNSPublication of a Prospectus
19th Dec 202312:22 pmRNSDirector/PDMR Shareholding
19th Dec 20237:15 amRNSTransaction in Own Shares
15th Dec 20235:50 pmRNSTransaction in Own Shares
14th Dec 20235:45 pmRNSTransaction in Own Shares
14th Dec 20237:15 amRNSTransaction in Own Shares
13th Dec 20237:15 amRNSTransaction in Own Shares
12th Dec 20237:15 amRNSTransaction in Own Shares
11th Dec 20237:15 amRNSTransaction in Own Shares
8th Dec 20237:15 amRNSTransaction in Own Shares
7th Dec 20237:15 amRNSTransaction in Own Shares
6th Dec 20237:15 amRNSTransaction in Own Shares
5th Dec 20237:15 amRNSTransaction in Own Shares
4th Dec 20237:15 amRNSTransaction in Own Shares
1st Dec 20232:48 pmRNSDirector/PDMR Shareholding
1st Dec 20239:44 amRNSIssue of equity and total voting rights
1st Dec 20237:15 amRNSTransaction in Own Shares
30th Nov 20237:15 amRNSTransaction in Own Shares
29th Nov 20237:20 amRNSTransaction in Own Shares
28th Nov 20237:15 amRNSTransaction in Own Shares
27th Nov 20237:15 amRNSTransaction in Own Shares
24th Nov 20237:15 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.